Fig. 1From: Abiraterone acetate and docetaxel with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer in China: an indirect treatment comparison and cost analysisRisk of bias assessment of the included studies: a risk of bias graph and b risk of bias summaryBack to article page